A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...
1d
Hosted on MSNArdelyx (ARDX) Earnings Expected to Grow: Should You Buy?The market expects Ardelyx (ARDX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...
BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...
The transplant, part of a three-person compassionate use study, used a pig kidney with 69 gene edits provided by U ...
Bioink manufacturers play an important role in bioprinting. Explore our list to see which companies are on the market.
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
As of 2:32:28 PM EST. Market Open. SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., February 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public ...
About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results